Get email alerts when ACRV insiders make a move — free, no credit card

ACRV Insider Trading & Form 4 Activity

Acrivon Therapeutics, Inc.
Last filing: May 26, 2026·13 days ago
NEUTRAL · LAST 90 DAYS
0%
buyers
$0
0 buys
$0
0 sells
$0
net buying
0
insiders
Tracking ACRV insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Blume-Jensen Peter
President and CEO
$0
Mirza Mansoor Raza
Chief Medical Officer
$0
Palani Santhosh
Director
$0
Shacham Sharon
Director
$0
RA CAPITAL MANAGEMENT, L.P.
Director
$0
Levy Adam D.
Chief Financial Officer
$0
Peterson Katharine
Chief Accounting Officer
$0
Gamelin Erick
Chief Development Officer
$0

Recent transactions

Every Form 4 transaction for ACRV, newest first.

TAX
Blume-Jensen Peter · President and CEO
Tx May 21·Filed May 26·EDGAR ↗
13,729 sh @ $1.79
$25K
AWARD
Mirza Mansoor Raza · Chief Medical Officer
Tx May 18·Filed May 20·EDGAR ↗
38,817 sh
AWARD
Palani Santhosh · Director
Tx May 18·Filed May 20·EDGAR ↗
9,366 sh
AWARD
Shacham Sharon · Director
Tx May 18·Filed May 20·EDGAR ↗
9,366 sh
AWARD
RA CAPITAL MANAGEMENT, L.P. · Director
Tx May 18·Filed May 20·EDGAR ↗
9,366 sh
AWARD
Levy Adam D. · Chief Financial Officer
Tx May 18·Filed May 20·EDGAR ↗
46,167 sh
AWARD
Blume-Jensen Peter · President and CEO
Tx May 18·Filed May 20·EDGAR ↗
180,095 sh
AWARD
Blume-Jensen Peter · President and CEO
Tx May 18·Filed May 20·EDGAR ↗
72,706 sh
AWARD
Peterson Katharine · Chief Accounting Officer
Tx May 18·Filed May 20·EDGAR ↗
14,227 sh
AWARD
Gamelin Erick · Chief Development Officer
Tx May 18·Filed May 20·EDGAR ↗
38,584 sh
AWARD
Devroe Eric · Chief Operating Officer
Tx May 18·Filed May 20·EDGAR ↗
72,981 sh
AWARD
DiRocco Derek · Director
Tx May 18·Filed May 20·EDGAR ↗
9,366 sh
AWARD
BAUM CHARLES M · Director
Tx May 18·Filed May 20·EDGAR ↗
9,366 sh
AWARD
Magovcevic-Liebisch Ivana · Director
Tx May 18·Filed May 20·EDGAR ↗
9,366 sh
AWARD
TOMSICEK MICHAEL JOHN · Director
Tx May 18·Filed May 20·EDGAR ↗
9,366 sh
AWARD
Miller Mary · Chief Legal Officer
Tx May 18·Filed May 20·EDGAR ↗
49,830 sh
TAX
Blume-Jensen Peter · President and CEO
Tx May 14·Filed May 18·EDGAR ↗
490 sh @ $1.92
$941
TAX
Gamelin Erick · Chief Development Officer
Tx May 14·Filed May 18·EDGAR ↗
404 sh @ $1.92
$776
TAX
Devroe Eric · Chief Operating Officer
Tx May 14·Filed May 18·EDGAR ↗
613 sh @ $1.92
$1K
TAX
Blume-Jensen Peter · President and CEO
Tx May 14·Filed May 18·EDGAR ↗
1,253 sh @ $1.92
$2K
TAX
Miller Mary · Chief Legal Officer
Tx May 14·Filed May 18·EDGAR ↗
184 sh @ $1.92
$353
TAX
Peterson Katharine · Chief Accounting Officer
Tx May 14·Filed May 18·EDGAR ↗
99 sh @ $1.92
$190

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About ACRV insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for ACRV from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying ACRV always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Acrivon Therapeutics, Inc. (ACRV) when they form.

Where does ACRV insider trading data come from?

Every Form 4 filing for ACRV is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai